OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
The potential benefits and harms associated with available treatments for ADHD in adults are unclear, especially when considering different types of interventions. We conducted a systematic review and a series of component network meta-analyses of 113 studies with 14,887 participants to jointly evaluate the performance of medications, psychological treatments, and neurostimulation at 12, 26, and 52 weeks. We evaluated these treatments against a common comparator (pill placebo) in terms of how well they reduced ADHD symptoms according to self-reports and clinician ratings, their acceptability (any-cause discontinuation), tolerability (discontinuation due to adverse events), and their effect on emotional dysregulation, executive dysfunctions, and quality of life.
This seminar is hosted in person and online, to join online, please use the Zoom details below:
zoom.us/j/93598736019?pwd=tHJ65nmXIrmYTUhi7YRbbdlnyi5Ie6.1
Meeting ID: 935 9873 6019
Passcode: 897963
